This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Home » Revisiting the Poison Prevention Packaging Act
In 1970, Richard Nixon signed into law the Poison Prevention Packaging Act (PPPA). The act was written in response to a growing number of child poisonings from unintentional ingestion of drugs and other products. The Act was successful, but a lot has changed in the last 47 years.
Back in 1970, as today, the dominant containers for pharmaceuticals in the U.S. were the bottle and vial. As the law was being written and child resistance (CR) being defined, two drastically different containers had to be regulated – the bottle, with hundreds of years of consumer experience, and the blister, having only come into the U.S. market in 1960, driven by a need for a specific dosing regimen required by a new drug for birth control.